Homecare Medicines Services for Immunoglobulin Therapies

The East of England NHS Collaborative Procurement Hub (the Authority) has procured a framework agreement for the provision of homecare medicines services for immunoglobulin therapy. This is for the dispensing and delivery of immunoglobulin products with associated equipment and ancillaries required for administration as well as options for associated nurse led care in the patients home and includes: - Intravenous immunoglobulin products - Sub-cutaneous immunoglobulin products - Patient self-injection training - Product administration in the patients home Estimated value at ~£100m for full maximum term (inc. product costs) ~£25m p.a. across EoECPH members (including affiliate members)